PubRank

18-Month Study of Curcumin (Curcumin)

Clinical Trial ID NCT01383161

PubWeight™ 4.78‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01383161

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984 119.59
2 Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991 49.03
3 Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 1996 10.60
4 Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 1999 10.45
5 Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001 7.68
6 A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology 2009 5.94
7 Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA 1997 5.09
8 Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A 2000 4.85
9 Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 1995 4.02
10 Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry 2002 2.80
11 Cholinergic fibre loss associated with diffuse plaques in the non-demented elderly: the preclinical stage of Alzheimer's disease? Acta Neuropathol 1997 0.95
12 Epigenetics: a novel therapeutic approach for the treatment of Alzheimer's disease. Pharmacol Ther 2013 0.90
13 A high incidence of apolipoprotein E epsilon4 allele in middle-aged non-demented subjects with cerebral amyloid beta protein deposits. Acta Neuropathol 1999 0.90
14 Curcumin as a therapeutic agent in dementia: a mini systematic review of human studies. ScientificWorldJournal 2014 0.83
15 Nutritional contributions to dementia prevention: main issues on antioxidant micronutrients. Genes Nutr 2014 0.79
16 Manganese superoxide dismutase in cancer prevention. Antioxid Redox Signal 2013 0.77
17 Natural Modulators of Amyloid-Beta Precursor Protein Processing. Curr Alzheimer Res 2012 0.76
18 Therapeutic Potential of Curcumin for the Treatment of Brain Tumors. Oxid Med Cell Longev 2016 0.75
Next 100